Accendra Health Inc (ACH) stock
ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.13−0.02 (-13.33%)
Close on Nov 13, 2026Market cap $10.00MP/E –Yield –
Accendra Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Accendra Health's operating income for the twelve months ending Sep 30, 2026 was $4.22M. For fiscal 2025 it was $27.46M. Over ten years it grew -18.0% a year on average. The highest annual figure on record is $368.47M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.46M | – |
| FY2024 | Dec 31, 2024 | -$217.73M | -263.4% |
| FY2023 | Dec 31, 2023 | $133.23M | -6.8% |
| FY2022 | Dec 31, 2022 | $142.91M | -61.2% |
| FY2021 | Dec 31, 2021 | $368.47M | +80.5% |
| FY2020 | Dec 31, 2020 | $204.12M | +179.0% |
| FY2019 | Dec 31, 2019 | $73.15M | – |
| FY2018 | Dec 31, 2018 | -$352.35M | -494.8% |
| FY2017 | Dec 31, 2017 | $89.25M | -55.3% |
| FY2016 | Dec 31, 2016 | $199.60M | -0.4% |
| FY2015 | Dec 31, 2015 | $200.36M | +25.6% |
| FY2014 | Dec 31, 2014 | $159.54M | -19.5% |
| FY2013 | Dec 31, 2013 | $198.08M | +0.7% |
| FY2012 | Dec 31, 2012 | $196.75M | -3.3% |
| FY2011 | Dec 31, 2011 | $203.52M | +3.9% |
| FY2010 | Dec 31, 2010 | $195.94M | -2.7% |
| FY2009 | Dec 31, 2009 | $201.28M | +11.4% |
| FY2008 | Dec 31, 2008 | $180.73M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.33M | -95.0% |
| Q2 FY2026 | Jun 30, 2026 | -$35.15M | – |
| Q1 FY2026 | Mar 31, 2026 | $17.13M | -13.5% |
| Q4 FY2025 | Dec 31, 2025 | $20.91M | – |
| Q3 FY2025 | Sep 30, 2025 | $26.47M | -14.8% |
| Q2 FY2025 | Jun 30, 2025 | -$39.71M | -334.7% |
| Q1 FY2025 | Mar 31, 2025 | $19.79M | +104.1% |
| Q4 FY2024 | Dec 31, 2024 | -$272.70M | -407.3% |
| Q3 FY2024 | Sep 30, 2024 | $31.08M | +30.4% |
| Q2 FY2024 | Jun 30, 2024 | $16.92M | +56.1% |
| Q1 FY2024 | Mar 31, 2024 | $9.70M | -1.1% |
| Q4 FY2023 | Dec 31, 2023 | $88.74M | – |
| Q3 FY2023 | Sep 30, 2023 | $23.84M | -60.4% |
| Q2 FY2023 | Jun 30, 2023 | $10.84M | -85.6% |
| Q1 FY2023 | Mar 31, 2023 | $9.81M | -83.9% |
| Q4 FY2022 | Dec 31, 2022 | -$53.48M | -186.2% |
| Q3 FY2022 | Sep 30, 2022 | $60.25M | -4.2% |
| Q2 FY2022 | Jun 30, 2022 | $75.09M | -22.5% |
| Q1 FY2022 | Mar 31, 2022 | $61.06M | -58.4% |
| Q4 FY2021 | Dec 31, 2021 | $62.02M | -35.1% |
| Q3 FY2021 | Sep 30, 2021 | $62.88M | -16.8% |
| Q2 FY2021 | Jun 30, 2021 | $96.88M | +336.5% |
| Q1 FY2021 | Mar 31, 2021 | $146.69M | +1263.8% |
| Q4 FY2020 | Dec 31, 2020 | $95.61M | +557.6% |
| Q3 FY2020 | Sep 30, 2020 | $75.55M | +189.4% |
| Q2 FY2020 | Jun 30, 2020 | $22.20M | +39.6% |
| Q1 FY2020 | Mar 31, 2020 | $10.76M | -35.2% |
| Q4 FY2019 | Dec 31, 2019 | $14.54M | – |
| Q3 FY2019 | Sep 30, 2019 | $26.11M | +22.3% |
| Q2 FY2019 | Jun 30, 2019 | $15.90M | – |
| Q1 FY2019 | Mar 31, 2019 | $16.60M | -31.4% |
| Q4 FY2018 | Dec 31, 2018 | -$225.87M | – |
| Q3 FY2018 | Sep 30, 2018 | $21.36M | -28.0% |
| Q2 FY2018 | Jun 30, 2018 | -$172.05M | -624.0% |
| Q1 FY2018 | Mar 31, 2018 | $24.22M | -31.8% |
| Q4 FY2017 | Dec 31, 2017 | -$8.77M | -117.9% |
| Q3 FY2017 | Sep 30, 2017 | $29.67M | – |
| Q2 FY2017 | Jun 30, 2017 | $32.84M | – |
| Q1 FY2017 | Mar 31, 2017 | $35.52M | – |
| Q4 FY2016 | Dec 31, 2016 | $49.01M | – |
See a number that looks wrong?